INTRODUCTION
============

Regeneration and reconstruction of human organs and tissue defects is one of the central challenges in modern medicine. There is a wide variety of different approaches to fill bone and joint defects, including tissue engineering, allograft transplantation, reimplantation of extracorporally treated autografts, or implantation of synthetic biomaterials. A major drawback of all reconstruction modalities is infection, thus requiring some kind of prophylaxis. Irradiation, autoclaving and chemical detergents are commonly used for disinfection of biomaterials and bone transplants, and might even allow reimplantation of infected or tumour-afflicted tissue after sterilisation. These conventional methods, however, severely alter biomechanical and biological properties of bone transplants \[[@R1]-[@R3]\]. Accordingly, there is an urgent clinical demand for alternative ways of treating contaminated human tissue and sterilization-sensitive biomaterials prior to implantation.

High hydrostatic pressure (HHP) as a means of food processing has been examined intensively for more than 100 years \[[@R4]\]. As most vegetative forms of micro-organisms are impaired by hydrostatic pressure in the range of 300-600 MPa, non-thermal inactivation of bacteria, yeasts, and moulds present in food such as jams, fruit juices, and dressings is now well-established. Furthermore, HHP proved a relatively mild disinfection method protecting taste and appearance of treated comestibles \[[@R4]\].

Recently, Diehl and co-workers have shown HHP to be a promising approach in orthopaedic surgery as well. Inactivation of normal tissue and various tumour cells could be demonstrated \[[@R5]-[@R7]\], with pressure levels leaving biomechanical properties of human bone, articular cartilage or tendon grafts unchanged \[[@R8]-[@R10]\]. Furthermore, no immunhistochemical changes were detectable in HHP treated tendon tissue \[[@R8]\], and biological activity of extracellular bone matrix proteins also remained unaffected \[[@R11]\].

Until now, HHP has not been introduced in the medical field for the disinfection of human tissue or heat-, gas-, or radiation-sensitive biomaterials. In this regard, the objective of the study was to assess HHP inactivation of clinically relevant bacteria on biomaterials and in human bone tissue under physiological conditions. Furthermore, different treatment protocols for maximum bacterial inactivation rates were evaluated in clinically oriented models. The hypothesis was that HHP is capable to completely disinfect both bacterial suspensions, as well as metallic implants and infected bone specimens.

MATERIALS AND METHODS
=====================

Preparation of Bacteria
-----------------------

Reference strains of *Enterococcus faecium* (ATCC 6057), *Staphylococcus* *aureus* (ATCC 25923) and *Pseudomonas aeruginosa* (ATCC 27853) were used for the *in vitro*studies. A methicillin resistant strain of *S. aureus* (MRSA 27065) isolated from a deep arthroplasty infection was also subjected to HHP treatment. Bacteria were cultured to late logarithmic growth phase in trypticase soy broth (TSB) at 37 °C overnight before testing. Bacterial cells were then washed twice in phosphate buffered saline, resuspended in normal saline (NaCl 0.9 %) and adjusted to 5 x 10^7^ cfu/ml by densitometry with McFarland standard (cfu = colony forming units).

Hydrostatic Pressure Treatment
------------------------------

HHP treatment was realised by a custom-made HHP device (RECORD Maschinenbau GmbH, Königssee, Germany) with temperature control. Pliable sample vials of a volume of 15 ml were completely filled with incubation fluid and vacuum sealed within a plastic foil to prevent implosion and leakage during pressure application. Pressurisation and decompression was performed with an average rate of 10 MPa/s and water used as transmission fluid. Pressure and temperature were continuously measured and regulated automatically during the HHP plateau time.

HHP Treatment of Bacterial Suspensions
--------------------------------------

Susceptibilities of suspended *E. faecium* ATCC 6057, *S.* *aureus* ATCC 25923 and *P. aeruginosa* ATCC 27853 toward HHP were determined (n = 5 for each group). In brief, bacterial suspensions of 10^5^ cfu/ml were prepared as described above and subjected to 600 MPa at 20°C for 10 min. Untreated suspensions served as a control (n = 5). Hereafter, serial aliquots of both test and control suspensions diluted with normal saline were plated on blood agar plates and incubated at 37°C. The number of cfu was quantified after 48 hours.

HHP Disinfection of Human Osteomyelitic Bone
--------------------------------------------

Bone biopsies from patients with chronic osteomyelitis or infected total joint arthroplasties that were gained during operative debridement were subjected to HHP treatment for proof-of-principle. Informed consent was obtained from all patients, and only bone specimens that had to be excised for surgical debridement were taken for the present investigation. To simulate a worst-case scenario, bacteria within the infected bone samples were enriched and incubated to stationary growth phase prior to pressure application. A total of 71 bone biopsies were obtained for HHP treatment in 21 operations (12 patients, mean age 67 years \[range 25 - 78\]).

Specimens were immediately placed in sterile Ringer´s solution in the operation theatre, transported to the laboratory on ice, transferred to TSB and incubated for 5 days at 37 °C. Thereafter, bacterial outgrowth was verified and the infecting bacteria were determined by standard microbiological techniques. Bone specimens with negative bacterial culture were discarded. Samples were exposed to HHP treatment under aseptic conditions as described above (for treatment parameters see Table **[1](#T1){ref-type="table"}**). At least one specimen of each operation served as a control and was not exposed to HHP. After pressure application, bone samples were transferred to sterile TSB and incubated for 5 days at 37 °C for assessment of bacterial survival.

HHP Treatment of Contaminated Biomaterial Surfaces
--------------------------------------------------

To determine the effectiveness of HHP for disinfection of contaminated biomaterials, a standard testing protocol modified after a national guideline was developed \[[@R12]\]. In brief, carefully cleaned and sterilized screws of stainless steel (DIN 84, standard size 6x20 mm) were used as substrates. Inoculum concentrations were adjusted to 10^6^ cfu/ml in defibrinized blood of adult sheep. Sterile screws were completely immersed in the infected blood for at least 1 minute and finally dried in Petri dishes at 37 °C for 24 hours.

Prior to treatment with HHP, the infected screws were placed in pliable plastic vials completely filled with 15 ml of TSB. The specimens were kept on ice before and after HHP treatment. Sample size was n = 5 for each experiment displayed in Table **[2](#T2){ref-type="table"}**, and untreated screws served as a control.

After pressure application, all screws were treated with ultrasound (55 kHz, Sonorex RK255H, Bandelin electronic, Berlin, Germany) for 7 min to remove adherent microorganisms, and serial dilutions of the bacterial suspensions were plated on blood agar plates. Finally, cfu were quantified after 48 hours of incubation at 37 °C.

HHP Treatment of Artificially Infected Bone Specimen
----------------------------------------------------

Human femoral heads of three patients receiving a total hip arthroplasty due to aseptic osteoarthritis were used for the *in vitro* bone infection model after informed consent was obtained. Average age was 69 years (44-71). The femoral heads were explanted and stored at -20 °C until examination. After defrosting at room temperature, bone cylinders with a diameter of 11 mm and a length of 10 mm were prepared from the specimens with a hollow drill under aseptic conditions.

Bacterial suspensions with an inoculum concentration of 10^5^ cfu/ml were prepared in TSB as described above. Bone cylinders were incubated in 5 ml of the bacterial suspension for 24 hours at 37 °C, transferred to sterile plastic vials filled with 15 ml of TSB, and subjected to HHP treatment. Bone specimens of the different test groups were either infected with *S. aureus* ATCC 25923, *E. faecium* ATCC 6057 or *P. aeruginosa* ATCC 27853. Thereafter, pressure levels of 600 MPa were applied for 10 min, 30 min or six five-minute intervals at 37 °C (n = 5 for each series).

After HHP treatment, the bone samples were transferred to 10 ml of TSB and incubated for 24 hours to determine bacterial growth (37 °C). Serial aliquots were taken, plated on blood agar plates and quantified after incubation for another 24 hours. If no bacterial growth was detected, incubation of the bone samples was prolonged until a total incubation period of 5 days was reached to assure disinfection (37 °C).

Statistical Analysis
--------------------

Means and standard deviations were determined whenever applicable. Statistical analysis was performed with Mann-Whitney-Test with P \< 0.05 considered significant.

RESULTS
=======

HHP Treatment of Bacterial Suspensions
--------------------------------------

Bacterial growth of all suspended strains was significantly reduced after HHP treatment compared to the untreated control (P \< 0.05). Both S. *aureus* ATCC 25923 and P. *aeruginosa* ATCC 27853 were completely inactivated by 10 min of 600 MPa, corresponding to a reduction of bacterial growth of at least 5 logarithmic levels. E. *faecium* ATCC 6057 on the other hand proved high barotolerance, and growth was only reduced to 62 ± 4 % of the control group.

HHP Disinfection of Human Osteomyelitic Bone
--------------------------------------------

Results of HHP treatment of osteomyelitic bone are displayed in Table **[1](#T1){ref-type="table"}**. Microbiological work-up revealed mono-infections in all cases. Nine samples did not show bacterial growth after enrichment and were discarded prior to HHP treatment. Finally, 62 specimens from 12 different patients were evaluated. Twenty-five samples served as a control, 2 were treated with 300 MPa, 7 were treated with 450 MPa and 28 samples were treated with 600 MPa (30 min; 20°C). Disinfection was achieved in 2 of the 37 treated specimens. All control samples showed positive bacterial growth.

HHP Treatment of Contaminated Biomaterial Surfaces
--------------------------------------------------

Bacterial growth on standard screws after HHP is displayed in Fig. (**[1](#F1){ref-type="fig"}**). Growth of *E. faecium* ATCC 6057 was not inhibited significantly by HHP treatment up to 600 MPa (*P* \> 0.05). *S. aureus*ATCC 25923 and MRSA 27065 on the other hand showed a significant reduction of growth with increasing pressure levels (*P* \< 0.01). After applying 400 MPa, only single colony forming units of both strains survived, and complete disinfection was achieved with 600 MPa (Fig. **[1](#F1){ref-type="fig"}**).

After modification of the treatment protocol, bacterial inactivation by HHP was even improved. As demonstrated for *S. aureus* ATCC 25923, both reduction of the treatment temperature in the pressure device to 4 °C as well as lengthening of the pressure plateau to 30 min significantly increased bacterial inactivation at 300 MPa (*P* \< 0.05). Complete inhibition of staphylococcal growth was already obtained with 300 MPa at 4°C or after 30 min of HHP, whereas 400 MPa and more were necessary for disinfection with a 10 min pressure plateau at 20 °C (Fig. **[2](#F2){ref-type="fig"}**).

HHP Treatment of Artificially Infected Bone Specimen
----------------------------------------------------

Antibacterial action of HHP in bone was evaluated after treatment with 600 MPa. Interestingly, some bone samples demonstrated unaffected bacterial growth after HHP ("non-responder"), whereas others were disinfected by HHP application ("responder"). Thus, results showed a high standard deviation.

Good antibacterial effectiveness of HHP could be demonstrated for *S. aureus*and *P. aeruginosa*, and the majority of bone specimens infected with these micro-organisms were completely disinfected (Fig. **[3](#F3){ref-type="fig"}**). Disinfection was achieved in 66 % of bone samples infected with *S. aureus*, and in 60 % of samples infected with *P. aeruginosa*. However, HHP failed to significantly reduce bacterial growth in single samples. Consequently, standard variations were high and no significant differences were observed between HHP treated and untreated control group (*P* \> 0.05). *E. faecium*again demonstrated high barotolerance. No sample was completely disinfected though viable bacteria were also reduced in some specimens. There was no significant difference in antibacterial effectiveness between the different treatment protocols (*P* \> 0.05), and neither prolongation of treatment nor iterating pressure application did overcome the baroprotective effect originated by the surrounding bone.

DISCUSSION
==========

Disinfection of infected autografts, allografts and biomaterials for therapy of bone defects is often associated with deterioration of mechanical, physical and biological properties. HHP technology is suggested as a novel approach, now being in preclinical testing with the aim to disinfect grafts and implants, and to inactivate both micro-organisms and tumour cells in resected tissue segments. By leaving the biomechanical and biological properties of bone, cartilage and tendons intact, HHP could improve quality of allografts and might even allow reimplantation of bone segments of patients with osteomyelitis or tumours after extracorporal HHP disinfection.

Antibacterial Effects of HHP
----------------------------

In the pressure range of biotechnological interest, hydrostatic pressure has in general no effect on covalent bonds. Therefore, natural compounds such as flavours, aromas, and dyes are not destroyed by HHP at room temperature. Nucleic acids also proved pressure resistant because their secondary structure is mainly stabilised by hydrogen bonds that are almost pressure insensitive. However, transcription and translation were reported to be regularly influenced by HHP \[[@R13]\]. The main targets of HHP seem to be membrane systems leading to an increased permeability of membranes and cell walls \[[@R14]\]. Shigehisa *et al*. reported an increased permeabilisation of bacterial cell walls by HHP followed by an elevated discharge of cytoplasmatic RNA \[[@R15]\], and membrane leakage after HHP treatment leading to increased intracellular staining was shown by Benito *et al*. \[[@R16]\]. Changes in membrane fluidity similar to those observed with thermal treatment and inactivation have been reported as well \[[@R17]\], and may explain the interactions of pressure and temperature. After adjustment of treatment parameters, successful inactivation of bacteria, moulds, yeasts, viruses and even bacterial spores has been described \[[@R18]\].

Results of our present study with suspended and surface-adherent bacteria confirmed the significant variations in pressure susceptibility reported in the literature even within bacterial species \[[@R16], [@R19]\], and results obtained for specific strains should therefore not be widely generalised. Both barosensitive and barotolerant strains had been selected.*P. aeruginosa*and *S. aureus*could be completely inactivated in suspension, whereas growth of *E. faecium* was only reduced by 38% even at HHP as high as 600 MPa. These differences in barotolerance were also reproduced with bacteria adhering to implants and bone. Although the molecular mechanisms of barotolerance have not been completely discovered, it is well renown that gram positive strains - like *E. faecium* - are generally more barotolerant than gram negative strains \[[@R23],[@R24]\]. Furthermore, single strains have shown barotolerance up to pressure levels of more than 1000 MPa \[[@R29]\]. In our study, the investigated strain of *E. faecium* that has been reported to be very heat resistant \[[@R12]\] has also demonstrated extraordinary pressure tolerance.

Influence of Media, Additives and Treatment Parameter on Bacterial Inactivation by HHP
--------------------------------------------------------------------------------------

Various investigations demonstrated that additives within the treatment media may have significant influence on bacterial barotolerance \[[@R20], [@R21]\]. In order to apply HHP for disinfection of bone and biomaterials, it is inevitable to proof uninhibited antibacterial effectiveness also in the presence of organic residua like proteins and blood. Thus, microbiological assays were performed with bacteria embedded in blood on screws, and with infected bone.

Our results provide evidence that blood does not alter bacterial inactivation by HHP compared to suspensions in TSB. In addition to these findings, we were able to demonstrate that both decreasing treatment temperature and prolonging pressure application allowed complete inactivation of *S. aureus* on contaminated screws already at decreased pressure levels (Fig. **[2](#F2){ref-type="fig"}**). As expected, susceptibility of *E. faecium* was not altered by the different treatment protocols up to 600 MPa of HHP (Fig. **[1](#F1){ref-type="fig"}**). Our results are thus in accordance with previously published data, demonstrating temperature levels above 50°C and below 5°C to increase bacterial inactivation by HHP \[[@R4], [@R19], [@R22]\]. Ludwig *et al*. explained the important influence of treatment temperature on the antibacterial effectiveness of HHP by changes in the membrane composition rendering bacteria more or less sensitive towards HHP \[[@R23]\]. Influence of temperature on inactivation again varies significantly between the different bacterial strains \[[@R24]\].

HHP Disinfection of Bone
------------------------

Femoral heads from patients with aseptic osteoarthritis, which are commonly used as allogeneic bone grafts, were infected *in vitro* and subjected to HHP to assess the influence of heterogeneous bone with areas of necrosis and sclerosis on the antibacterial effectiveness of HHP. Interestingly, the heterogeneous constitution of the bone specimens was reflected by an enormous variation of bacterial inactivation by HHP. Various bone specimens could be completely disinfected, whereas others proved resistant to treatment with unaffected bacterial growth (Fig. **[3](#F3){ref-type="fig"}**). Histological and biochemical parameters of the different bone samples were not correlated to the inactivation rates in the present work and should be addressed in future studies.

Apart from the *in vitro* experiments, we were able to demonstrate that HHP is also capable to reduce bacterial growth in human osteomyelitic bone ex vivo. However, complete disinfection of the human bone specimens was only achieved in 2 out of 37 samples. "Worst case scenarios'' have been simulated in the test assay with enrichment of the infecting micro-organisms prior to HHP application. After the enrichment period, a very high bacterial load was reached with most bacteria in stationary phase being less susceptible to HHP \[[@R25]\]. Thus, pressurisation can be expected to be more effective if applied directly to the microbiota of the collected specimens.

Our findings clearly indicate that bone can protect embedded bacteria from HHP, since *S. aureus*and *P. aeruginosa* were reproducibly inactivated in suspension and in blood, but not in bone. An explanation for the baroprotective effect of bone might be a lack of water molecules, which are known to enhance the pressure effect, and water was less present in the examined dry bone samples compared to bacterial suspensions. The influence of different bone constituents on HHP inactivation of micro-organisms might also play an important role and has been studied for other reasons. An increased fat content is typical for degenerative bone diseases. However, Gervilla *et al*. did not observe any baroprotective effect of the fat content within the treatment medium on pressurised bacteria \[[@R26]\]. Different results have been reported for sugars like sucrose \[[@R27]\] and divalent cations. Especially Ca^2+^ demonstrated a dose-dependent baroprotective effect \[[@R28]\].

We anticipate that HHP can be established as a disinfection method to reduce viability of barotolerant microorganisms on heat-, gas- and radiation-sensitive biomaterials. Although bacteria were effectively eradicated in single infected specimens, HHP failed to safely disinfect both infected bone samples as well as infected metal implants. Antibacterial efficacy can be increased with elevated pressure levels and adjusted treatment temperature. Indications might however be limited to mono-infections with barotolerant bacteria. Contamination of screws with infected blood had no influence on bacterial inactivation by HHP, compared to the same bacteria in suspension. Disinfection of bone allografts, however, was significantly limited by a baroprotective effect of bone tissue, and the underlying mechanisms of these specimens resistant to therapy have to be addressed in further studies.
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###### 

Bone Specimens of Patients with Osteomyelitis were Obtained, Incubated and Subjected to High Hydrostatic Pressure (HHP, 20°C, 30 min)

  ----------------------------------------------------
  Bacteria\            HHP\      Samples After\
  Pre-Treatment        \[MPa\]   HHP (Sterile/Total)
  -------------------- --------- ---------------------
  *S. aureus*          450       0 / 7

  *S. aureus*          600       1 / 17

  *S. aureus*& CNS     600       0 / 3

  CNS                  600       0 / 6

  *Escherichia coli*   300       0 / 2

  *Escherichia coli*   600       1 / 2
  ----------------------------------------------------

Table 1 shows the isolated micro-organisms and results after pressure treatment.

CNS = coagulase negative staphylococci.

###### 

Treatment Parameters for the Application of HHP to Disinfect Stainless Steel Screws

  Exp.   Bacterial Strain         Pressure Levels \[MPa\]   Temperature \[°C\]   Pressure Time \[Min.\]
  ------ ------------------------ ------------------------- -------------------- ------------------------
  1      *S. aureus* ATCC 25923   0, 200, 300, 400          20                   10
  2      *S. aureus* ATCC 25923   0, 200, 300, 400          4                    10
  3      *S. aureus* ATCC 25923   0, 200, 300, 400          4                    30
  4      *S. aureus* ATCC 25923   0, 200, 300, 400          20                   30
  5      MRSA 27065               0, 200, 300, 400          20                   10
  6      *E. faecium* ATCC 6057   0, 200, 300, 400          20                   10
  7      *S. aureus* ATCC 25923   0, 200                    20                   30
  8      *S. aureus* ATCC 25923   0, 200                    20                   6 x 5
